Poly Medicure balance sheet

As of Mar 2026

Total assets: ₹3,919cr+22.7% on Mar 2025
Shareholders' equity: ₹3,149cr+13.9% on Mar 2025
Total debt: ₹342cr+92.3% on Mar 2025
Cash and investments: ₹790cr−25.8% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1,255	1,038	819	587
	90.5	89.7	66.7	72.6
	—	0.0	0.6	0.9
	274	28.6	28.6	28.6
	157	15.2	16.0	16.0
	8.2	11.4	9.0	5.6
	15.2	13.2	7.1	7.6
	0.6	7.3	20.4	0.0
	18.6	20.3	13.3	11.3
	19.2	27.6	33.8	11.3
	73.6	0.3	0.0	0.0
	84.1	51.3	36.8	40.3
	1,977	1,275	1,017	770
	434	286	221	209
	739	1,057	140	119
	531	350	270	235
	51.2	8.7	12.1	7.1
	36.6	143	135	176
	0.7	0.3	0.2	0.3
	45.5	7.8	12.8	7.4
	1,404	1,566	569	545
	103	65.6	51.2	53.6
	1,942	1,917	842	807
	3,919	3,192	1,859	1,577
Equity
	50.7	50.7	48.0	48.0
	3,055	2,715	1,422	1,194
	3,106	2,766	1,470	1,242
	43.1	—	—	—
	3,149	2,766	1,470	1,242
Liabilities
	52.1	0.0	1.1	17.5
	41.1	1.4	2.8	2.0
	93.2	1.4	3.9	19.5
	31.1	9.4	6.0	4.6
	58.0	42.9	24.5	15.4
	10.0	0.0	0.0	0.0
	194	56.6	37.4	42.3
	290	178	169	129
	123	86.4	95.6	92.3
	95.7	69.9	54.0	37.8
	508	334	319	259
	2.6	0.4	0.6	0.6
	8.6	6.8	3.6	0.8
	56.4	29.0	28.4	32.8
	576	370	351	293
	769	427	389	336
	3,919	3,192	1,859	1,577
Liabilities — additional as-filed lines
	1.6	3.0	3.0	2.7
Trade payables — MSME split
	16.0	11.3	—	—
	107	75.1	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

POLYMED₹1,461.90

Poly Medicure Ltd.

· Pharma & Health

₹ CrorePeersPFIZER RAINBOW ONESOURCE KIMS JUBLPHARMA VIJAYA INDGN GRANULESMcap ₹14,818 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	587.3	818.5	1,038.1	1,255.2	1,255.2
+ Capital Work-in-Progress	72.6	66.7	89.7	90.5	90.5
+ Investment Property	0.9	0.6	0.0	—	—
+ Goodwill	28.6	28.6	28.6	273.8	273.8
+ Other Intangibles	16.0	16.0	15.2	157.1	157.1
+ Intangibles under Development	5.6	9.0	11.4	8.2	8.2
+ Investments (Equity Method)	7.6	7.1	13.2	15.2	15.2
+ Non-current Investments	0.0	20.4	7.3	0.6	0.6
+ Other Non-current Financial Assets	11.3	13.3	20.3	18.6	18.6
Non-current Financial Assets	11.3	33.8	27.6	19.2	19.2
+ Deferred Tax Assets	0.0	0.0	0.3	73.6	73.6
+ Other Non-current Assets	40.3	36.8	51.3	84.1	84.1
Total Non-current Assets	770.2	1,017.0	1,275.5	1,976.8	1,976.8
Current Assets
+ Inventories	208.7	221.0	285.6	433.8	433.8
+ Current Investments	118.6	139.5	1,056.6	739.2	739.2
+ Trade Receivables	235.4	269.9	349.7	531.2	531.2
+ Cash & Cash Equivalents	7.1	12.1	8.7	51.2	51.2
+ Other Bank Balances	176.0	134.8	142.6	36.6	36.6
+ Short-term Loans	0.3	0.2	0.3	0.7	0.7
+ Other Current Financial Assets	7.4	12.8	7.8	45.5	45.5
Current Financial Assets	544.8	569.4	1,565.8	1,404.4	1,404.4
+ Other Current Assets	53.6	51.2	65.6	103.4	103.4
Total Current Assets	807.0	841.6	1,917.0	1,941.7	1,941.7
Total Assets	1,577.2	1,858.7	3,192.5	3,918.6	3,918.6
Equity
+ Equity Share Capital	48.0	48.0	50.7	50.7	50.7
+ Other Equity / Reserves	1,193.7	1,422.1	2,715.0	3,055.5	3,055.5
Equity — Owners of Parent	1,241.6	1,470.1	2,765.7	3,106.2	3,106.2
+ Minority Interest	—	—	—	43.1	43.1
Total Equity	1,241.6	1,470.1	2,765.7	3,149.2	3,149.2
Liabilities
+ Borrowings — Non-current	17.5	1.1	0.0	52.1	52.1
+ Other Non-current Financial Liab	2.0	2.8	1.4	41.1	41.1
Non-current Financial Liabilities	19.5	3.9	1.4	93.2	93.2
+ Provisions — Non-current	4.6	6.0	9.4	31.1	31.1
+ Deferred Tax Liabilities	15.4	24.5	42.9	58.0	58.0
+ Other Non-current Liabilities	0.0	0.0	0.0	10.0	10.0
Non-current Liabilities	42.3	37.4	56.6	193.8	193.8
+ Borrowings — Current	128.9	169.1	177.6	289.5	289.5
+ Trade Payables	92.3	95.6	86.4	122.7	122.7
+ Other Current Financial Liab	37.8	54.0	69.9	95.7	95.7
Current Financial Liabilities	259.1	318.7	333.9	507.9	507.9
+ Provisions — Current	0.6	0.6	0.4	2.6	2.6
+ Current Tax Liabilities	0.8	3.6	6.8	8.6	8.6
+ Other Current Liabilities	32.8	28.4	29.0	56.4	56.4
Current Liabilities	293.3	351.2	370.2	575.5	575.5
Total Liabilities	335.6	388.6	426.8	769.3	769.3
Total Equity & Liabilities	1,577.2	1,858.7	3,192.5	3,918.6	3,918.6
Liabilities — additional as-filed lines
+ Deferred Government Grants — Non-current	2.7	3.0	3.0	1.6	1.6
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	11.3	16.0	16.0
+ Dues to Other Creditors — Current	—	—	75.1	106.7	106.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.